Type 1 diabetes mellitus following SARS-CoV-2 mRNA vaccination

PURPOSE: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) vaccines have been reported to trigger immune side effects. Type 1 diabetes as a manifestation of autoimmune/inflammatory syndrome induced by adjuvants has been reported in a limited number of cases after vaccinations. A few type...

Descripción completa

Detalles Bibliográficos
Autores principales: Aydoğan, Berna İmge, Ünlütürk, Uğur, Cesur, Mustafa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9282628/
https://www.ncbi.nlm.nih.gov/pubmed/35809159
http://dx.doi.org/10.1007/s12020-022-03130-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9282628/
https://www.ncbi.nlm.nih.gov/pubmed/35809159
http://dx.doi.org/10.1007/s12020-022-03130-8

Ejemplares similares